These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 53111

  • 1. 35-S-antithyroid drug concentration and organic binding of iodine in the human thyroid.
    Lazarus JH, Marchant B, Alexander WD, Clark DH.
    Clin Endocrinol (Oxf); 1975 Nov; 4(6):609-15. PubMed ID: 53111
    [Abstract] [Full Text] [Related]

  • 2. The placental transfer of propylthiouracil, methimazole and carbimazole.
    Marchant B, Brownlie BE, Hart DM, Horton PW, Alexander WD.
    J Clin Endocrinol Metab; 1977 Dec; 45(6):1187-93. PubMed ID: 591614
    [Abstract] [Full Text] [Related]

  • 3. Mechanism of action of thioureylene antithyroid drugs: factors affecting intrathyroidal metabolism of propylthiouracil and methimazole in rats.
    Nakashima T, Taurog A, Riesco G.
    Endocrinology; 1978 Dec; 103(6):2187-97. PubMed ID: 748042
    [Abstract] [Full Text] [Related]

  • 4. The metabolism of 35S-labelled antithyroid drugs in thyrotoxic, adenomatous, neoplastic and normal human thyroid.
    Lazarus JH, Marchant B, Alexander WD, Clark DH.
    Clin Sci; 1973 Jun; 44(6):24P. PubMed ID: 4123392
    [No Abstract] [Full Text] [Related]

  • 5. Mechanism of action of thioureylene antithyroid drugs in the rat: possible inactivation of thyroid peroxidase by propylthiouracil.
    Shiroozu A, Taurog A, Engler H, Dorris ML.
    Endocrinology; 1983 Jul; 113(1):362-70. PubMed ID: 6861708
    [Abstract] [Full Text] [Related]

  • 6. Propylthiouracil and methimazole display contrasting pathways of peripheral metabolism in both rat and human.
    Taurog A, Dorris ML.
    Endocrinology; 1988 Feb; 122(2):592-601. PubMed ID: 3338414
    [Abstract] [Full Text] [Related]

  • 7. Effects of chronic treatment of intact and hypophysectomized rats with thyroid-stimulating hormone on the metabolism of [35S]methimazole and [35S]propylthiouracil.
    Lees JF, Alexander WD.
    Endocrinology; 1978 Oct; 103(4):1394-400. PubMed ID: 744151
    [Abstract] [Full Text] [Related]

  • 8. Influence of sodium perchlorate on thiourylene antithyroid drug accumulation in mice.
    Connell JM, Ferguson MM, Chang DS, Alexander WD.
    J Endocrinol; 1983 Aug; 98(2):183-7. PubMed ID: 6308122
    [Abstract] [Full Text] [Related]

  • 9. [Metabolism of thioureylene antithyroid drugs--particularly with relationship between intrathyroidal metabolism of the drugs and the mechanisms of action (author's transl)].
    Nakashima T.
    Rinsho Byori; 1982 Feb; 30(2):170-8. PubMed ID: 6177885
    [No Abstract] [Full Text] [Related]

  • 10. Triiodothyronine and thyroxine in hyperthyroidism. Comparison of the acute changes during therapy with antithyroid agents.
    Abuid J, Larsen PR.
    J Clin Invest; 1974 Jul; 54(1):201-8. PubMed ID: 4134836
    [Abstract] [Full Text] [Related]

  • 11. Metabolism of 35S-labelled antithyroid drugs in man.
    Alexander WD, Evans V, MacAulay A, Gallagher TF, Londono J.
    Br Med J; 1969 May 03; 2(5652):290-1. PubMed ID: 4180995
    [Abstract] [Full Text] [Related]

  • 12. The acclumulation of 35 S-antithyroid drugs by the thyroid gland.
    Marchant B, Alexander WD, Lazarus JH, Lees J, Clark DH.
    J Clin Endocrinol Metab; 1972 May 03; 34(5):847-51. PubMed ID: 4111035
    [No Abstract] [Full Text] [Related]

  • 13. Excretion of methimazole in human milk.
    Johansen K, Andersen AN, Kampmann JP, Mølholm Hansen JM, Mortensen HB.
    Eur J Clin Pharmacol; 1982 Oct 03; 23(4):339-41. PubMed ID: 6897386
    [Abstract] [Full Text] [Related]

  • 14. Rapid conversion of carbimazole to methimazole in serum; evidence for an enzymatic mechanism.
    Nakashima T, Taurog A.
    Clin Endocrinol (Oxf); 1979 Jun 03; 10(6):637-48. PubMed ID: 476986
    [Abstract] [Full Text] [Related]

  • 15. Thyroid Ca2+/NADPH-dependent H2O2 generation is partially inhibited by propylthiouracil and methimazole.
    Ferreira AC, de Carvalho Cardoso L, Rosenthal D, de Carvalho DP.
    Eur J Biochem; 2003 Jun 03; 270(11):2363-8. PubMed ID: 12755690
    [Abstract] [Full Text] [Related]

  • 16. Inhibitory effects of methimazole and propylthiouracil on iodotyrosine deiodinase 1 in thyrocytes.
    Yoshihara A, Luo Y, Ishido Y, Usukura K, Oda K, Sue M, Kawashima A, Hiroi N, Suzuki K.
    Endocr J; 2019 Apr 25; 66(4):349-357. PubMed ID: 30814441
    [Abstract] [Full Text] [Related]

  • 17. In vitro immunoreactivity to propylthiouracil, methimazole, and carbimazole in patients with Graves' disease: a possible cause of antithyroid drug-induced agranulocytosis.
    Wall JR, Fang SL, Kuroki T, Ingbar SH, Braverman LE.
    J Clin Endocrinol Metab; 1984 May 25; 58(5):868-72. PubMed ID: 6200492
    [Abstract] [Full Text] [Related]

  • 18. Antithyroid Drugs Inactivate TSH Binding to the TSH Receptor by their Reducing Action.
    Ochi Y, Hachiya T, Koyama Y, Fukuhori N, Ashida N.
    Endocr Metab Immune Disord Drug Targets; 2018 May 25; 18(5):508-512. PubMed ID: 29468987
    [Abstract] [Full Text] [Related]

  • 19. SIDE EFFECTS OF PTU AND MMI IN THE TREATMENT OF HYPERTHYROIDISM: A SYSTEMATIC REVIEW AND META-ANALYSIS.
    Yu W, Wu N, Li L, Wang J, OuYang H, Shen H.
    Endocr Pract; 2020 Feb 25; 26(2):207-217. PubMed ID: 31652102
    [Abstract] [Full Text] [Related]

  • 20. Pharmacokinetics of antithyroid drugs.
    Benker G, Reinwein D.
    Klin Wochenschr; 1982 Jun 01; 60(11):531-9. PubMed ID: 6180218
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.